NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-27 16:53இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Omaxe Q2 FY27 Consolidated Revenue Up 77% YoY to ₹613.91 Cr, Net Loss Narrows to ₹25.55 Cr
Omaxe reported a 77.2% YoY increase in consolidated total income from operations to ₹613.91 Cr for the quarter ended September 30, 2026, compared to ₹346.36 Cr in Q2 FY26. Consolidated net loss narrowed sharply to ₹25.55 Cr compared to a loss of ₹166.42 Cr in the prior-year period, though slipping from a small profit of ₹1.30 Cr in the trailing quarter. On a standalone basis, the company delivered a net profit after tax of ₹50.49 Cr on revenue of ₹310.40 Cr. The filing also noted ongoing legal challenges, including a review petition before SAT against an adverse order and evaluation of a SEBI order regarding Minimum Public Shareholding compliance.
உச்சம் நம்பிக்கை
என்ன மாறியதுOmaxe reported Q2 and H1 FY27 results showing substantial revenue expansion and sharply lower net losses compared to the heavy losses incurred across FY26.
ஏன் இது முக்கியம்Consolidated H1 FY27 revenue of ₹1,052.85 Cr reaches ~76% of FY26 full-year revenue (₹1,377 Cr TTM), showing a sharp acceleration in execution and project recognition that could help stem historical cash burn.
Consolidated Revenue (Q2 FY27): ₹613.91 கோடிConsolidated Net Loss (Q2 FY27): ₹-25.55 கோடிH1 FY27 Revenue vs TTM Revenue: ~76.5%Standalone Net Profit (Q2 FY27): ₹50.49 கோடி
📅 குறுகிய காலம்The substantial top-line jump and standalone turnaround provide positive operational momentum, though regulatory overhangs will remain on investor radar.
📈 நீண்ட காலம்Sustained revenue recognition from commercial projects (e.g., Omaxe Chowk, Dwarka) is crucial to offset high leverage and repair negative consolidated net reserves.
⚠ அபாய எச்சரிக்கைகள்
Regulatory order from SEBI regarding Minimum Public Shareholding compliance
Adverse SAT order dated September 1, 2026, currently under review application
Negative consolidated Other Equity balance of ₹-1,084.42 Cr as of March 31, 2026
👀 கவனிக்க வேண்டியவை
Track whether consolidated operations can sustain operational turnaround into consistent net profits in Q3, alongside monitoring developments in the SAT review petition and SEBI Minimum Public Shareholding proceedings.
Omaxe Inks MoU with Lemon Tree for 10 Hotels (4,000 Keys) at ₹4,000 Cr Investment
Omaxe has signed an MoU with Lemon Tree Hotels' subsidiary, Carnation Hotels, to operate 10 hotel projects comprising 4,000 keys across India. The projects entail an estimated investment of ~₹4,000 crore, representing ~290% of Omaxe's TTM revenue of ₹1,377 crore and exceeding its current market cap of ₹1,930 crore. The initiative is part of Omaxe's broader ₹6,200 crore hospitality rollout covering 19 hotels. Omaxe plans to utilize a sale-led development model to fund completion via sales proceeds without relying on project loan debt.
உச்சம் நம்பிக்கை
என்ன மாறியதுOmaxe entered into an operational partnership MoU with Lemon Tree Hotels to run 10 upcoming hospitality projects totaling 4,000 keys.
ஏன் இது முக்கியம்The ₹4,000 crore project pipeline accelerates Omaxe's transition into commercial/hospitality real estate, but execution relies heavily on customer pre-sales amidst historical operating losses.
Estimated investment: ₹4,000 கோடிInvestment vs TTM revenue: ~290%Total hotel keys: 4,000 keysOverall hospitality plan: ₹6,200 கோடிExecution timeline: 9 months to 5 years
📅 குறுகிய காலம்Market sentiment may be buoyed by the marquee brand association with Lemon Tree, though near-term financials will remain driven by ongoing residential collections and loss containment.
📈 நீண்ட காலம்If successfully executed via the sale-led model, this could structurally diversify cash flows toward commercial and hospitality formats over the next 3 to 5 years.
⚠ அபாய எச்சரிக்கைகள்
Arrangement is currently structured as an MoU rather than a definitive agreement
Company reported a TTM net loss of ₹510 crore, making capital discipline and customer pre-sales critical
Extended execution timeline (up to 5 years) poses cost escalation and delivery risks
👀 கவனிக்க வேண்டியவை
Track conversion of this MoU into binding definitive agreements and monitor pre-sales cash flow generation to ensure execution without exacerbating the company's existing balance sheet stress.
SEBI Debars Omaxe for 3 Months, Promoters for 1 Year; Levies Rs 27 Lakh Penalty
SEBI has issued an order dated September 24, 2026, restraining Omaxe Limited from accessing the securities market and prohibiting it from dealing in securities for three months over non-compliance with Minimum Public Shareholding (MPS) and PFUTP regulations. Key promoters and associated entities, including Rohtaas Goel and Sunil Goel, have been restrained from the securities market for one year. SEBI also imposed a monetary penalty of Rs 27 lakh on Omaxe and between Rs 27 lakh to Rs 37 lakh on other noticees. The company stated it is evaluating legal remedies against the order.
உச்சம் நம்பிக்கை
என்ன மாறியதுSEBI passed an order on September 24, 2026, imposing market bans and financial penalties on Omaxe and its promoters due to MPS and PFUTP non-compliance.
ஏன் இது முக்கியம்While the Rs 27 lakh penalty is financially minor relative to FY26 revenue of Rs 1,253.4 Cr, the securities market ban restricts equity fundraises, and governance concerns could affect investor sentiment.
Penalty on Omaxe Limited: ரூ. 27 லட்சம்Company market ban duration: 3 மாதங்கள்Promoter market ban duration: 1 ஆண்டுPenalty on Noticees 2, 3, 4 (each): ரூ. 37 லட்சம்
📅 குறுகிய காலம்Negative sentiment overhang is likely in the immediate term as markets price in regulatory debarment and governance overhang.
📈 நீண்ட காலம்Limits immediate equity capital-raising flexibility during the restraint period, though regular real estate operational activities remain unaffected.
👀 கவனிக்க வேண்டியவை
Track whether the company or promoters appeal the order before the Securities Appellate Tribunal (SAT) to seek an interim stay, and assess any resulting constraints on corporate financing.
SAT Dismisses Omaxe & Promoters' Appeal Against July 2024 SEBI Order on Alleged PFUTP Violations
The Securities Appellate Tribunal (SAT) in Mumbai, via an order dated September 1, 2026, has dismissed Appeal No. 568 of 2024 filed by Omaxe Limited, promoters, and key executives against a July 30, 2024 SEBI order. The underlying SEBI allegations pertain to violations of SEBI PFUTP regulations, Listing Regulations, the Companies Act, and applicable Accounting Standards. Omaxe stated it is evaluating legal remedies, noting no new material financial impact beyond previous disclosures.
உச்சம் நம்பிக்கை
என்ன மாறியதுSAT has upheld the July 30, 2024 SEBI order by dismissing Omaxe's appeal, removing interim appellate relief.
ஏன் இது முக்கியம்Confirmation of regulatory violations involving PFUTP and accounting standards elevates corporate governance risks and may trigger operational, financial, or market access restrictions on the company and key management.
SAT Order Date: செப்டம்பர் 1, 2026Date of Order Receipt: செப்டம்பர் 2, 2026Original SEBI Order Date: ஜூலை 30, 2024Appeal Number: Appeal No. 568 of 2024
📅 குறுகிய காலம்Likely negative sentiment overhang on the stock as the tribunal dismissal upholds SEBI's adverse findings against the company and promoters.
📈 நீண்ட காலம்Sustained regulatory scrutiny and potential penalties or restrictions can increase cost of capital and delay planned corporate initiatives.
⚠ அபாய எச்சரிக்கைகள்
Adverse regulatory ruling on fraud/PFUTP and accounting compliance
Potential escalation to the Supreme Court of India
Promoter and executive involvement in regulatory violations
👀 கவனிக்க வேண்டியவை
Track whether Omaxe and its promoters appeal the SAT dismissal before the Supreme Court of India and monitor any regulatory restrictions or penalties enforced post-dismissal.
Omaxe Clarifies SAT Pronounced Order in SEBI Financial Misstatement Appeal; Copy Awaited
Omaxe Limited clarified to exchanges following news reports that the Securities Appellate Tribunal (SAT) pronounced its order on September 1, 2026, regarding the company's appeal against SEBI's July 30, 2024 order. The original SEBI order alleged misstatements and financial irregularities against Omaxe, its Chairman, and others, against which SAT had granted an interim stay on October 1, 2024 following penalty deposit. Omaxe confirmed that the formal written order has not yet been uploaded or received, meaning the exact directives and financial/operational implications remain pending assessment.
உச்சம் நம்பிக்கை
என்ன மாறியதுSAT has pronounced its verdict on Omaxe's appeal against SEBI's 2024 order on financial statement irregularities, with the full written order pending publication.
ஏன் இது முக்கியம்Potential upholding of SEBI's regulatory action could impose corporate governance sanctions, debarments, or additional financial liabilities on a company already facing net losses (TTM PAT of Rs -510 Cr).
Original SEBI order date: ஜூலை 30, 2024Interim stay order date: அக்டோபர் 1, 2024Order reserved date: ஜூலை 7, 2026SAT order pronouncement date: செப்டம்பர் 1, 2026Penalty deposited: வெளியிடப்படவில்லை
📅 குறுகிய காலம்Market sentiment and stock price may face overhang until the exact operational and financial directives in the SAT order are disclosed.
📈 நீண்ட காலம்Structural governance scrutiny and confirmed accounting irregularities can impair credit ratings, debt refinancing costs, and institutional investor interest.
⚠ அபாய எச்சரிக்கைகள்
Regulatory penalties and governance overhang
Potential management restrictions or debarment
Weak standalone/consolidated profitability (TTM PAT Rs -510 Cr)
👀 கவனிக்க வேண்டியவை
Watch for the company's detailed disclosure once the written SAT order is uploaded, specifically checking for any management debarment, financial penalties, or appeal plans before the Supreme Court.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Omaxe Obtains Punjab RERA Approval; Sets Launch Date for Patiala Commercial Project on Aug 19, 2026
Omaxe Limited has received the Punjab RERA registration certificate for its commercial plotted project, 'PDA Omaxe City Commercial', situated in Patiala, Punjab. The project is officially scheduled for launch on August 19, 2026, with the regulatory registration valid until December 31, 2030. This approval formally authorizes the company to market, advertise, and sell the plotted units. Specific revenue potential, project area, and capital outlay were not disclosed in the filing.
உச்சம் நம்பிக்கை
என்ன மாறியதுOmaxe secured RERA clearance allowing the commercial plotted project in Patiala to be marketed and sold starting August 19, 2026.
ஏன் இது முக்கியம்Enables sales monetization and booking cash inflows in Punjab, supporting the company's operational recovery following a TTM loss of Rs 510 Cr.
Project Launch Date: 19-08-2026RERA License Validity: 31-12-2030Project Value / Size: வெளியிடப்படவில்லைTTM Revenue (Context): Rs 1377 கோடி
📅 குறுகிய காலம்Commencement of marketing and advance customer bookings from August 19, 2026 may modestly improve working capital inflows.
📈 நீண்ட காலம்Aligns with Omaxe's strategy of monetizing commercial land holdings in Tier 2/3 northern cities, though broader turnaround hinges on execution across larger flagship projects.
⚠ அபாய எச்சரிக்கைகள்
Project financial size, area, and estimated sales value not disclosed
Real estate market absorption and execution risks in Tier-2 locations
Elevated historical losses and debt burden (TTM PAT Rs -510 Cr, Debt Rs 506 Cr)
👀 கவனிக்க வேண்டியவை
Track subsequent quarterly operational updates for pre-sales velocity, launch collections, and revenue recognition from this Patiala project.
Omaxe Reports Rs 1.30 Cr Consolidated PAT in Q1 FY27, Turning Profitable YoY
Omaxe Limited achieved a consolidated net profit of Rs 1.30 Cr for the quarter ended June 30, 2026, a significant turnaround from a loss of Rs 185.77 Cr in the same period last year. Total income from operations grew 47.3% YoY to Rs 438.94 Cr, representing approximately 35% of its TTM revenue in a single quarter. However, the standalone entity remains loss-making with a net loss of Rs 31.88 Cr. A key regulatory overhang persists as the Securities Appellate Tribunal (SAT) has reserved its order regarding a 2024 SEBI ruling against the company.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has shifted from deep quarterly losses to a marginal consolidated profit, driven by a 47% surge in quarterly revenue.
ஏன் இது முக்கியம்After reporting a TTM loss of Rs 697 Cr, this profitable quarter suggests improved revenue recognition from major projects, though high debt and legal disputes remain structural concerns.
Consolidated Revenue (Q1): Rs 438.94 கோடிConsolidated PAT (Q1): Rs 1.30 கோடிRevenue vs TTM Revenue: ~35%Standalone Net Loss: Rs 31.88 கோடிConsolidated EPS: Rs 0.05
📅 குறுகிய காலம்The stock may see positive sentiment as the company breaks its streak of heavy losses, though the reserved SAT order remains a near-term risk.
📈 நீண்ட காலம்Sustainability depends on the successful execution of high-value projects like Dwarka and Omaxe Chowk to offset high interest costs and standalone-level losses.
⚠ அபாய எச்சரிக்கைகள்
Pending SAT final order on SEBI litigation
Persistent standalone losses
High debt-to-equity ratio of 1.10
👀 கவனிக்க வேண்டியவை
Monitor the upcoming SAT final order which could impact management stability, and track if consolidated profitability can be sustained beyond this quarter given the ongoing standalone losses.
Omaxe Subsidiary Receives RERA Approval for Lucknow Commercial Project Valid Till 2030
Omaxe Limited's wholly-owned subsidiary, Omaxe Garv Buildtech Private Limited, has secured RERA registration for its 'Commercial-3 Block-4' project in Lucknow, UP. The project is scheduled for launch on August 12, 2026, with the registration valid until December 17, 2030. This regulatory milestone allows the company to commence sales and marketing activities for the commercial block. For a company with a TTM revenue of • 1,253 Cr and significant net losses of • 697 Cr, new project launches are essential for generating the cash flow needed to service its • 506 Cr debt.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned from the planning phase to the legal sales/marketing phase for a specific commercial block in Lucknow following RERA approval.
ஏன் இது முக்கியம்New commercial launches are central to Omaxe's strategy to pivot toward high-value retail infrastructure to offset losses in residential segments and manage high interest costs of 14-15%.
📅 குறுகிய காலம்The announcement is a positive procedural step that allows the company to start generating advances from customers, potentially improving short-term liquidity.
📈 நீண்ட காலம்The project contributes to Omaxe's stated goal of launching projects with a total value exceeding • 20,000 Cr, which is necessary for long-term financial recovery.
⚠ அபாய எச்சரிக்கைகள்
High interest rates (14-15%) on project debt
Negative operating margins (-55.5%)
Ongoing litigations and tax disputes totaling • 685.61 Cr
👀 கவனிக்க வேண்டியவை
Investors should monitor the sales velocity and collection efficiency of this Lucknow project to see if it can improve the company's negative operating margin of -55.5%.
₹6,200 Cr Investment: Omaxe Launches Hospitality Vertical with 19 New Hotels
Omaxe has announced a massive strategic pivot by launching a dedicated hospitality vertical with a proposed investment of ₹6,200 crore over the next 4-5 years. The plan involves developing 19 hotels (5 million sq. ft.) across 13 cities in 5 states, aiming for ₹1,000 crore in annual revenue upon stabilization. This investment is highly significant, representing over 430% of the company's current market capitalization (₹1,434 Cr). While the move targets recurring revenue through PPP models and partnerships like IHCL, the company currently faces deep financial stress with TTM losses of ₹697 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுOmaxe is diversifying its business model from pure-play real estate development to include a large-scale hospitality vertical focused on recurring revenue.
ஏன் இது முக்கியம்The scale of this expansion is nearly five times the company's current annual revenue, representing a high-stakes attempt to transform its financial profile and create stable cash flows through hospitality assets.
Total Proposed Investment: ₹6,200 கோடிInvestment vs Market Cap: 432.3%Target Annual Revenue: ₹1,000 கோடிTotal Planned Hotels: 19Development Area: 5 million sq. ft.
📅 குறுகிய காலம்The stock may see speculative interest due to the massive investment figure, but gains may be capped by concerns over the company's ability to fund such large capex given its current losses.
📈 நீண்ட காலம்If executed successfully, this could structurally change Omaxe's revenue mix toward stable hospitality income; however, execution and debt-servicing risks remain extremely high.
⚠ அபாய எச்சரிக்கைகள்
Funding risk (Capex is 4.3x Market Cap)
High existing TTM losses (₹697 Cr)
Execution risk in PPP projects
High interest rate environment (14-15% on existing debt)
👀 கவனிக்க வேண்டியவை
Investors should closely monitor the funding roadmap for this ₹6,200 crore capex, as the company is currently loss-making with negative operating margins. Key milestones to watch include definitive agreements with international hotel operators and the execution timeline of the Dwarka PPP project.
Omaxe Limited has approved the allotment of 156 Unrated Senior Secured Non-Convertible Debentures (NCDs) on a private placement basis, raising Rs 15.60 crore. This is the fifth tranche of a larger fundraise program totaling up to Rs 199.40 crore, with 1,102 NCDs allotted to date. The instruments offer a committed return of 12% IRR and are secured by project assets and multiple corporate and personal guarantees. The tenure is set for up to 54 months from the initial allotment date of July 2025.
முக்கிய அம்சங்கள்
Allotment of 156 NCDs with a face value of Rs 10 lakh each, aggregating to Rs 15.60 crore.Part of a larger issuance program of up to 1,994 NCDs totaling Rs 199.40 crore.Offers a committed return of 12% IRR with a 3% IRR penalty for payment delays.Secured by exclusive first charge on project land, receivables, and bank accounts of specific projects in Chandigarh and Delhi NCR.Total NCDs allotted under this specific program now reach 1,102 units.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's leverage levels and the execution progress of the 'Grand Omaxe' and 'Resort-A&B' projects used as collateral. The use of unrated instruments at a 12% IRR indicates a high-cost debt structure that requires close observation of cash flow management.
WSB Partners Invests ₹75 Crore in Omaxe Group for Tier II Residential Projects
Omaxe Limited has secured an investment of ₹75 crore from WSB Partners, a real estate-focused investment firm. The capital is specifically targeted at residential plotted projects in the high-growth Tier II markets of Indore and Ujjain. The funds will be utilized primarily as growth capital to accelerate project development, alongside allocations for working capital and reserves. This move signifies strong institutional interest in Omaxe's expansion strategy within emerging urban corridors.
முக்கிய அம்சங்கள்
Investment of ₹75 crore secured from WSB Partners and co-investorsFunding targeted at residential plotted developments in Indore and UjjainCapital to be deployed for growth, working capital, and project reservesOmaxe has delivered 140.17 million sq. ft. of real estate across 31 cities to dateWSB Partners has a track record of committing ₹4,000 crore across 75+ investments since 2013
👀 கவனிக்க வேண்டியவை
Investors should monitor the progress of the Indore and Ujjain projects as they represent a key growth driver in the Tier II segment. The institutional backing from WSB Partners provides a positive signal regarding Omaxe's project viability and liquidity.
Omaxe Reports Net Loss for FY26; SEBI Legal Proceedings and Auditor Changes Announced
Omaxe Limited reported a net loss for both the quarter and the full financial year ended March 31, 2026, on a consolidated and standalone basis. While the auditors provided an unmodified opinion, they highlighted an 'Emphasis of Matter' regarding a SEBI order from July 2024, which is currently stayed by the Securities Appellate Tribunal (SAT). The company has also appointed new internal and cost auditors for FY 2026-27, following the resignation of the previous internal auditor due to other assignments. The next hearing for the regulatory matter is scheduled for July 7, 2026.
முக்கிய அம்சங்கள்
Reported a net loss (including other comprehensive loss) for the quarter and financial year ended March 31, 2026.Ongoing legal matter regarding a SEBI order dated July 30, 2024, with a stay currently in place from SAT.Next SAT hearing for the SEBI regulatory matter is set for July 7, 2026.Appointment of M/s Aditya V Agarwal & Company as Internal Auditors for FY 2026-27.Consolidated financial results include the performance of 144 group companies and 2 associate companies.
👀 கவனிக்க வேண்டியவை
Investors should remain cautious due to the reported losses and the regulatory uncertainty surrounding the SEBI order. Monitor the outcome of the SAT hearing on July 7, 2026, as it may impact corporate governance sentiment.
Omaxe Subsidiary Receives RERA Approval for Two Commercial Projects in Lucknow; Launch May 7
Omaxe Limited's wholly-owned subsidiary, Omaxe Garv Buildtech Private Limited, has received RERA registration certificates for two commercial projects in Lucknow, Uttar Pradesh. The projects, Commercial-3 Block-1 and Block-2, are officially scheduled for launch on May 7, 2026. These approvals allow the company to legally advertise, sell, and transfer units, which is expected to positively impact consolidated financial performance. The registrations are valid until December 17, 2030, providing a clear timeline for project execution.
முக்கிய அம்சங்கள்
Received RERA registration for two commercial projects: Commercial-3 Block-1 and Block-2 in Lucknow.Official launch date for both commercial blocks is set for May 7, 2026.RERA registration numbers UPRERAPRJ914738/05/2026 and UPRERAPRJ627399/05/2026 obtained.Project approvals are valid for a period ending December 17, 2030.Enables the subsidiary to commence sales and marketing, strengthening brand value and future revenue.
👀 கவனிக்க வேண்டியவை
Investors should track the sales momentum and booking updates from these Lucknow projects as they will be critical for the company's cash flow in the coming quarters. The RERA compliance reduces regulatory risk and allows for immediate monetization of the assets.
Omaxe Announces Rs 250 Cr Investment in Lucknow Project; 83% Units Pre-sold
Omaxe Limited, through its wholly-owned subsidiary, has announced a Rs 250 crore investment in its new residential project 'Omaxe Cassia' in Lucknow. The project has demonstrated strong market demand, with 300 out of 360 units already sold as construction begins. Located within the 690-acre Omaxe Metro City township, the development features eight towers of 2BHK and 3BHK apartments. The company aims to complete and deliver the project within a three-year timeframe in compliance with RERA regulations.
முக்கிய அம்சங்கள்
Investment of approximately Rs 250 crore for the development of 'Omaxe Cassia' in LucknowStrong sales traction with 300 out of 360 units (83%) already sold before full-scale constructionProject includes 8 towers offering a mix of 2BHK and 3BHK apartmentsPart of the larger 690-acre Omaxe Metro City township on Raebareli RoadSlated for completion and delivery within the next three years
👀 கவனிக்க வேண்டியவை
Investors should view the high pre-sales velocity as a positive indicator of cash flow visibility and brand strength in the Uttar Pradesh market. Monitor the company's ability to maintain construction timelines to ensure timely revenue recognition.
Omaxe Subsidiary Gets RERA Approval for Lucknow Commercial Project Valid Until 2030
Omaxe Limited's wholly-owned subsidiary, Omaxe Garv Buildtech Private Limited, has secured RERA registration for its 'COMMERCIAL-3 BLOCK-3' project in Lucknow. The registration (UPRERAPRJ787830/04/2026) is valid until December 17, 2030, allowing the company to officially commence sales and marketing activities. This commercial development in Sarojini Nagar is expected to contribute to the company's consolidated revenue and strengthen its brand presence in Uttar Pradesh. The approval ensures regulatory compliance and provides legal protection for potential buyers, fostering trust and transparency.
முக்கிய அம்சங்கள்
Wholly-owned subsidiary Omaxe Garv Buildtech Private Limited received RERA registration for 'COMMERCIAL-3 BLOCK-3' in Lucknow.The RERA registration (UPRERAPRJ787830/04/2026) is valid for a period ending December 17, 2030.The approval enables the company to immediately start the sale, transfer, and advertising of the commercial project.The project is located in Sarojini Nagar, Lucknow, across multiple Khasra numbers including 635(P) and 2156(P).
👀 கவனிக்க வேண்டியவை
Investors should monitor the sales velocity and cash flow generation from this new commercial project as it will impact future earnings. The stock remains a watch for execution efficiency in the Lucknow real estate market.
Omaxe Receives RERA Approval for 'Omaxe Royal Nest' Project in Ludhiana
Omaxe Limited has successfully obtained RERA registration for its new residential plotted project, 'Omaxe Royal Nest,' located in Ludhiana, Punjab. The project is officially scheduled for launch on April 23, 2026, with the regulatory license valid until January 31, 2031. This approval is a critical milestone as it permits the company to begin advertising, sales, and transfers for the project. Management expects this development to strengthen brand value and positively contribute to the company's consolidated financial performance.
முக்கிய அம்சங்கள்
Received RERA Registration (PBRERA-LDH44-PR1370-042026) for the 'Omaxe Royal Nest' project in Ludhiana.Official project launch date set for April 23, 2026, targeting the Residential (Plotted) category.The regulatory license is valid for a period of nearly 5 years, expiring on January 31, 2031.Project designed to cater to both domestic and international markets to maximize sales reach.
👀 கவனிக்க வேண்டியவை
Investors should track the sales booking numbers for this project in upcoming quarterly updates to gauge its impact on cash flows. The RERA certification mitigates regulatory risks and allows the company to monetize its land bank in Punjab.
Omaxe Subsidiary Secure Properties Raises ₹40 Crore via NCDs
Omaxe Limited's step-wholly owned subsidiary, Secure Properties Private Limited, has successfully raised ₹40 crore through a private placement. The capital was raised via the issuance of 400 unlisted, unrated, senior, secured, redeemable non-convertible debentures (NCDs). Each NCD carries a face value of ₹10 lakh. This move indicates the group's active efforts to secure liquidity for its subsidiary operations.
முக்கிய அம்சங்கள்
Raised ₹40 Crore through step-wholly owned subsidiary Secure Properties Private LimitedIssued 400 Unlisted, Unrated, Senior, Secured, Redeemable, Non-Convertible Debentures (NCDs)Each NCD has a face value of ₹10 LakhThe fundraise was completed via private placement as per SEBI LODR Regulations
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's debt-to-equity ratio and the specific interest rates on these unrated instruments to assess the cost of capital. The ability to raise funds at the subsidiary level is a positive sign for project liquidity.
Omaxe Limited has approved the allotment of 313 Unrated Senior Secured Non-Convertible Debentures (NCDs) on a private placement basis, raising Rs 31.30 crore. This is the fourth tranche of a larger fundraising program totaling up to Rs 199.40 crore, with 946 NCDs allotted to date. The NCDs offer a committed return of 12% IRR and are backed by extensive security, including mortgages on project land and personal guarantees. The tenure is set for 54 months from the initial allotment date of July 16, 2025.
முக்கிய அம்சங்கள்
Allotment of 313 NCDs with a face value of Rs 10 lakh each, aggregating to Rs 31.30 croreCumulative allotment reaches 946 NCDs out of a total planned issue of 1,994 NCDs (Rs 199.40 crore)Instruments carry a 12% IRR committed return with a 54-month tenure from July 2025Secured by first charge on project land in Chandigarh and other locations, plus personal and corporate guaranteesAdditional 3% IRR penalty applicable in case of payment defaults exceeding three months
👀 கவனிக்க வேண்டியவை
Investors should note the high cost of capital (12% IRR) and the unrated nature of the debt, which reflects the company's current risk profile. Monitor the company's project execution and cash flow generation to ensure it can meet these high-yield redemption obligations.
Omaxe Unveils "Pink Stand" at ₹2,500 Cr Dwarka Project; Partners with IHCL and Bentel
Omaxe Limited is developing 'The Omaxe State' in Dwarka, a massive ₹2,500 crore integrated sports and lifestyle destination spread over 50 acres. The project features a 30,000-seater stadium, which now includes a dedicated 1,500-seat 'Pink Stand' named after cricketer Harmanpreet Kaur to enhance inclusivity. The development is a 5-in-1 destination comprising a 48,000 sq.mt. retail high-street, a 158-key five-star Gateway Hotel by IHCL, and a membership-based sports club. This flagship project, developed in partnership with the DDA, positions Omaxe as a key player in high-value urban infrastructure in the NCR.
முக்கிய அம்சங்கள்
Total investment of approximately ₹2,500 crore for a 50-acre integrated sports and retail hub in Dwarka.Stadium features a 30,000-seat capacity with a dedicated 1,500+ seat 'Pink Stand' for women and families.Partnership with IHCL for a 158-key five-star Gateway Hotel and Bentel Associates for architectural master planning.Development includes 48,000 sq.mt. of retail space and a 30,000 sq.mt. indoor-outdoor sports center.Infrastructure designed to international standards for hosting global events like the Olympics and FIFA.
👀 கவனிக்க வேண்டியவை
Investors should track the construction milestones and pre-leasing activity of the retail and hospitality components, as this project represents a significant portion of Omaxe's future revenue potential. The involvement of global consultants and IHCL significantly de-risks the commercial viability of the development.
Omaxe Subsidiaries Secure RERA Approvals for Two Major Residential Projects in Punjab and UP
Omaxe Limited's wholly-owned subsidiaries have received RERA registration certificates for two residential projects, enabling immediate sales and marketing activities. The 'Integrated Residential Township Phase 6B' in New Chandigarh is valid until December 1, 2030, while the 'METRO CITY P-8B' project in Lucknow is valid until October 9, 2027. Both projects are scheduled for launch on March 23, 2026, targeting both domestic and international buyers. These approvals are expected to positively impact the company's consolidated financial performance by unlocking new inventory for sale.
முக்கிய அம்சங்கள்
Received RERA registration for Integrated Residential Township Phase 6B in Punjab, valid until Dec 1, 2030Obtained RERA approval for METRO CITY P-8B in Lucknow, UP, with validity until Oct 9, 2027Both residential plotted projects are officially set for launch on March 23, 2026Approvals grant legal clearance to advertise, sell, and transfer units, facilitating future cash inflows
👀 கவனிக்க வேண்டியவை
Investors should track the booking numbers and sales velocity of these two projects post-launch to gauge the impact on near-term revenue. The successful acquisition of RERA licenses mitigates regulatory risk and provides a clear path for project execution.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
